Impact Genetics provides cost-effective, high quality genetic testing for rare diseases.
In collaboration with our leading scientists and clinical care providers, we continually refine tests to maximize sensitivity. New scientific discoveries, genetic data and clinical knowledge flow freely to maximize health impact. Impact Genetics’ service delivery team is committed to supporting doctors and genetic specialists with outstanding service.
June 4th, 2014 – NEW TEST FOR UVEAL MELANOMA. Impact has launched a new prognostic test for Uveal Melanoma. This genetic test identifies the risk of metastasis, indicating survival prognosis in patients with Uveal Melanoma. More information.
We offer the following clinical genetic tests in our CAP/CLIA certified lab.
- Retinoblastoma (RB)
Highly sensitive genetic testing to inform clinical care of Retinoblastoma patients and their families. more
- Hereditary Hemorrhagic Telangiectasia (HHT)
Highly sensitive genetic testing to aid in HHT diagnosis and care of patients and families. more
- Uveal Melanoma (UM)
Most comprehensive genetic test to determine chance of survival without metastatic disease. more
Why choose us?
- Cost effective
- Documented high diagnostic sensitivity
- Provided by disease experts
- Flexible billing and personal support
- Quick turn-around times
- Comprehensive and informative reports